Juvenescence https://validator.w3.org/feed/docs/rss2.html Mohamad Hamade Biotech Company Juvenescence Completes Phase 1 Trial of PAI-1 Inhibitor Catherine McClinton Eric Verdin, our collaborator in the Buck institute presents data on our compound Jim Mellon presenting at UBS Year Ahead conference Our Director of IR, Yehudah Nevies, presenting at Singapore Week of Innovation & Technology Jim on Panel at Abu Dhabi Investment Forum in London Richards interview to Jo Shorthouse New Medicines for the Healthspan Revolution | M42 Demystifying Biotechnology: A Deep Dive into Juvenescence | M42 Eileen Jennings-Brown Listen in to the interview to hear our co-founder Dr. Greg Bailey discussing Juvenescence strategy Juvenescence Appoints Eileen Jennings-Brown as CTO and Strengthens UAE Presence in Masdar City’s Life Science Innovation Cluster We are proud to Sponsor and host The Longevity forum in London Greg Bailey: Biotech can add another 10 healthy years to your life Our CSO, Gill Dines at ARDD Conference Rosalba presenting data from our core medicine Juvenescence: Think aging up, rather than disease down Chrysea presents additional study results at Gordon Research Conference (GRC) Team at Middle East Investors Summit Presenting at several conferences in the UAE Relation Therapeutics announces $1.7B strategic collaboration with Novartis to advance therapeutics for Atopic Diseases Greg at Founders forum Our Team Dr Kersten Small Paul Russell Our Approach HydraScreen: A Generalizable Structure-Based Deep Learning Approach to Drug Discovery Ro5 Bioactivity Lab: Identification of Drug Candidates for COVID-19 SE(3) Equivariant Topologies for Structure-based Drug Discovery Benchmarking ML in ADMET predictions: the practical impact of feature representations in ligand-based models Accelerated hit identification with target evaluation, deep learning and automated labs: prospective validation in IRAK1 Fiona McCarrick The Simple Biotech Podcast: ‘Investing in the Longevity Industry: The Greatest Investment Opportunity in Human History’ Yehudah Nevies Juvenescence closes $76m first tranche of Series B-1 financing led by Abu Dhabi’s M42 alongside strategic partnership Privacy Notice Juvenescence acquires AI drug discovery company Ro5 to boost R&D capabilities and drive pipeline of medicines to extend healthy lifespan Biomarkers of Aging Consortium Dr Rosalba The Longevity Forum Buck Institute for Research on Aging WHX Dubai Jeff M Bio Hevolution Foundation Incredible week at Abu Dhabi Global Health Week First day at the The Longevity Forum in London Morphoceuticals Dr. Carmel Nanthakumar